PASITHEA THERAPEUTICS CORP. Sale of Stock, Consideration Received Per Transaction
PASITHEA THERAPEUTICS CORP. (KTTA) reported Sale of Stock, Consideration Received Per Transaction of $2.08 million for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-13.
Financial Statements › Notes › Equity
us-gaap:SaleOfStockConsiderationReceivedPerTransaction · last filed 2025-11-13
- PASITHEA THERAPEUTICS CORP. sale of stock, consideration received per transaction for the quarter ending 2025-09-30 was $0.00.
| Period end | Sale of Stock, Consideration Received Per Transaction 3 month | Sale of Stock, Consideration Received Per Transaction 6 month | Sale of Stock, Consideration Received Per Transaction 9 month |
|---|---|---|---|
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $2.08M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $2.08M 10-Q · filed 2025-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Rocket One Inc. (RKTO) | United States | $0.019B |